Ascendis Pharma A ASND
NASDAQ ASND
$238.90 +4.57 (+1.95%)
At close: Oct 21, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Non-Current Assets (2012 - 2026)

Updated

Ascendis Pharma A's Non-Current Assets was $1.04 billion in the quarter ended Jun 30, 2026, up 581.5% from $152.75 million a year earlier and up 0.9% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Non-Current Assets (2012 - 2026) Analysis & Trends

As of Dec 31, 2025, Non-Current Assets at Ascendis Pharma A came in at $218.71 million, down 89.9% from the prior year.

  • Non-Current Assets shows a five-year compound annual growth rate of 61.6% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Non-Current Assets was $2.16 billion in the year ended Dec 31, 2024, $132.91 million in the year ended Dec 31, 2023 (-24.2%), $175.24 million in the year ended Dec 31, 2022 (-86.3%) and $1.28 billion in the year ended Dec 31, 2021.
  • The figure for the quarter ended Jun 30, 2026 marks the highest quarterly Non-Current Assets since the quarter ended Dec 31, 2024.
  • Compared with a year earlier, Non-Current Assets was higher in four of the last seven quarters, with growth averaging 158.1%.
  • The best year-over-year quarter for Non-Current Assets over five years was the quarter ended Mar 31, 2026 (growth of 600.6%); the worst was the quarter ended Dec 31, 2025 (a decline of 89.4%).
  • Per Business Quant data, ASND's Non-Current Assets in the three quarters before the quarter ended Jun 30, 2026 was $1.03 billion (quarter ended Mar 31, 2026), $225.34 million (quarter ended Dec 31, 2025) and $160.12 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 141.29 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 101.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 87.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 159.77 Bn
10 Ascendis Pharma A 14.48 Bn 10.74 Bn 362.22 Mn 1.02 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Bn
Mar 31, 2026 1.01 Bn
Dec 31, 2025 227.41 Mn
Sep 30, 2025 160.68 Mn
Jun 30, 2025 158.26 Mn
Mar 31, 2025 151.48 Mn
Dec 31, 2024 2.07 Bn
Sep 30, 2024 134.09 Mn
Jun 30, 2024 140.26 Mn
Mar 31, 2024 149.39 Mn
Dec 31, 2023 135.99 Mn
Sep 30, 2023 148.18 Mn
Jun 30, 2023 158.83 Mn
Mar 31, 2023 170.58 Mn
Dec 31, 2022 177.25 Mn
Sep 30, 2022 190.22 Mn
Jun 30, 2022 224.33 Mn
Mar 31, 2022 285.93 Mn
Dec 31, 2021 316.01 Mn
Sep 30, 2021 288.47 Mn
API Access

Ascendis Pharma A Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ASND&period=max&api_key=YOUR_API_KEY